Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein-Barr

Kimberly A Bauer1, Angela K Brimhall2, Timothy T Chang1

  • 1Department of Dermatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio.

Pediatric Dermatology
|October 21, 2011
PubMed

Insights

A rare drug reaction with eosinophilia and systemic symptoms (DRESS) occurred in a child treated with azithromycin during an Epstein-Barr virus infection. Prompt recognition of DRESS syndrome is crucial for pediatric patients.

Area of Science:

  • Pediatric Medicine
  • Pharmacovigilance
  • Infectious Diseases

Background:

  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a severe hypersensitivity reaction.
  • Azithromycin is a commonly prescribed antibiotic, particularly in pediatric populations.
  • Acute Epstein-Barr virus (EBV) infection is prevalent in children and adolescents.

Observation:

  • An 8-year-old boy developed DRESS following azithromycin administration for acute EBV infection.
  • Clinical manifestations included fever, rash, eosinophilia, and hypotension.
  • The patient required intensive care unit admission due to the severity of symptoms.

Findings:

  • This case represents the first reported pediatric DRESS associated with azithromycin during an EBV infection.
  • The patient recovered fully without long-term complications after supportive care.
  • Highlights the potential for severe drug reactions even with common antibiotics in the context of viral infections.

Implications:

  • Emphasizes the need for careful consideration of antibiotic use in patients with acute viral infections like EBV.
  • Underscores the importance of recognizing DRESS syndrome's clinical signs for timely intervention in pediatric cases.
  • Suggests a potential interaction between azithromycin and EBV infection leading to severe hypersensitivity reactions.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.